Neoplasia/BPH

	Focal Cryotherapy in Prostate Cancer. Does Gleason Impact Results? Int Braz J Urol Mate K, de Pablos-Rodríguez P, Herraiz MB, Román MH, Gómez PP, Fons AC, García MIM, Aliaga JP, Cortés MB, Lozano ÁG, Escrig S JLD, Castañé CG, Part VR, Borja JLCR. PMID: 41576188 [PubMed - indexed for MEDLINE]
	Robot-assisted Partial Nephrectomy with and without Mixed Reality - REALITATEM study. Int Braz J Urol Duarte DM Junior, Brum PW, Berger M, Kowalski A, Silva B Neto, Berger AK. PMID: 41576183 [PubMed - indexed for MEDLINE]
	Transperineal Laser Ablation for Treatment of Lower Urinary Tract Symptoms in Benign Prostate Enlargement: A Systematic Review and Meta-analysis. Int Braz J Urol Pires IZ, Gobbo MODS, Fujimura AY Jr, Milbradt TL, Sudo RYU, Pereira M, Marquardt N Filho, Carvalhal GF, Averbeck MA. PMID: 41576182 [PubMed - indexed for MEDLINE]
	Comment on "The role of apparent diffusion coefficient values in diagnosing prostate cancer for patients with equivocal PI-RADS 3 lesions: a multicenter retrospective study". Int J Surg Wang A. PMID: 41576064 [PubMed - as supplied by publisher]
	Time-Dependent Comparative Effectiveness of First-Line Treatment for Metastatic Clear Cell Renal Cell Carcinoma: A Restricted Mean Survival Time-Based Network Meta-analysis. Target Oncol Fukushima H, Yajima S, Chen W, Hirakawa A, Tanabe K, Fujiwara M, Arita Y, Tanaka H, Masuda H, Fujii Y, Yoshida S. PMID: 41575641 [PubMed - as supplied by publisher]
	P.I. nomogram: an exploratory imaging-derived model for predicting early urinary incontinence following ThuLEP. World J Urol Lan XD, Jiang R, Wang H, Mulati Y, Zhang K, Zhang Q, Wu J, Meng Y, Meng YS. PMID: 41575593 [PubMed - indexed for MEDLINE]
	Decision tree models combining Bi-parametric vesical imaging reporting and data system and apparent diffusion coefficient metrics for predicting muscle-invasive bladder cancer. Abdom Radiol (NY) Sugawara D, Hatakeyama K, Konno M, Tozawa T, Sato T, Murata T, Murasawa E, Narita S, Nanjo H, Habuchi T, Mori N. PMID: 41575494 [PubMed - as supplied by publisher]
	TFE-Altered Renal Cell Carcinoma: A Contemporary Review With Practical Insights and Diagnostic Pearls for Surgical Pathologists. Adv Anat Pathol Przybycin CG, Nguyen JK, Alaghehbandan R. PMID: 41574499 [PubMed - as supplied by publisher]
	Recent Advances in Understanding the Biological Role of microRNA-371a-3p in Testicular Germ Cell Tumors. Andrology Klemke M, Belge G, Dieckmann KP. PMID: 41574394 [PubMed - as supplied by publisher]
	The role of neuroendocrine differentiation in treatment resistance of prostate cancer and intervention strategies. Front Oncol Wang B, Zhang Y, Zhang W. PMID: 41573638 [PubMed]
	Assessing digital rectal examination and prostate-specific antigen knowledge: a study of Syrian medical students' knowledge for prostate cancer screening. BMC Med Educ Al-Shafie M, Al-Bitar A, Jouby M, Hiba I, Tello MK, Saifo M. PMID: 41572262 [PubMed - as supplied by publisher]
	Accuracy, readability, and understandability of EAU guidelines bot for testicular cancer. Int Urol Nephrol Gallo G, Lombardo R, Pagliarulo V, Sequi MB, Coppola LM, Rosato E, Romagnoli M, De Cillis S, Checcucci E, Amparore D, Ragonese M, Foschi N, Santarelli V, Spatafora P, Tema G, Nacchia A, Cicione A, Franco A, Pastore AL, Al Salhi Y, Rocco B, Gacci M, Fiori C, Finazzi Agrò E, Sciarra A, Tubaro A, De Nunzio C, Next-Gen Research Group. PMID: 41572051 [PubMed - as supplied by publisher]
	ReIMAGINE study insights: Can abbreviated bpMRI transform prostate cancer screening? Eur Radiol Muglia VF, Verma S. PMID: 41572046 [PubMed - as supplied by publisher]
	Contemporary management of locally advanced prostate cancer: a narrative review and expert perspective. World J Urol Kafka M, Heidegger I. PMID: 41572035 [PubMed - in process]
	Active Surveillance Versus Intravesical Bacillus Calmette-GuÃ©rin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol Kitamura H, Tsukamoto T, Kakehi Y, Mizusawa J, Shibata T, Sasaki K, Tanikawa T, Hashine K, Fujimoto K, Masumori N, Kobayashi T, Habuchi T, Kimura T, Sugimoto M, Takahashi A, Adachi H, Matsui Y, Hatakeyama S, Ito A, Eto M, Nishiyama H, Urologic Oncology Study Group of the Japan Clinical Oncology Group. PMID: 41571573 [PubMed - as supplied by publisher]
	Natural product-mediated autophagy targeting for prostate cancer: A novel potential therapeutic strategy. Phytomedicine Zhang M, Zhong J, Yu M, Wang J, Zhang T, Liu M, Zhang P. PMID: 41571467 [PubMed - as supplied by publisher]
	[Therapy-Associated Neuroendocrine Prostate Cancer (tNEPC): A Diagnostic and Therapeutic Challenge in Uro-Oncology with Emerging Clinical Implications]. Aktuelle Urol von Amsberg G, Hartmann A, Eckstein M, Heidegger I. PMID: 41571001 [PubMed - as supplied by publisher]
	Cyclin D1 and the resistance landscape of HIF2 inhibition in clear-cell renal cell carcinoma: Insights from a mini-review. Biochem Biophys Res Commun Zhong Z, Yang A, Wang J, Tian Y, Ma B, Liu X. PMID: 41570697 [PubMed - as supplied by publisher]
	Evaluation of Loss of the Y Chromosome in Peripheral Blood as a Biomarker for Prostate Cancer. Prostate Lu J, Lu Y, Kobayashi T, Hachiya T, Wakita H, Jin Y, Tanaka Y, Ikehata Y, Nagata M, Ide H, Horie S. PMID: 41570183 [PubMed - as supplied by publisher]
	Effect of Celecoxib Combined With Low-Dose-Rate Brachytherapy on Long-Term Oncological Outcomes and Quality of Life in Prostate Cancer: Post Hoc Analysis of an Open-Label Controlled Randomized Trial. Prostate Nakai Y, Onishi K, Asakawa I, Miyake M, Yamaki K, Isohashi F, Fujimoto K, Tanaka N. PMID: 41570179 [PubMed - as supplied by publisher]

Articles 1 - 20 / 184845

Page 1 of 9243



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy